RP

Ragunath Priyadharshini

Director Managing Director DIN 08735774
DIN 08735774 First appointment May 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2020
Shareholding value •••• Premium profile

About Ragunath Priyadharshini

Data last updated:

Ragunath Priyadharshini was a Managing Director at Medigro Pharmaceutical Private Limited (2020–2021) and Managing Director at Amartyaa Pharmaceutical Private Limited (2020–2021). The companies operate in Pharma.

DIN 08735774
Primary Designation Managing Director
Industry Pharma
First Appointment 31 May 2020

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director31 May 20202020₹8.3 Lakh (FY 2024)Active
Managing Director09 Dec 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medigro Pharmaceutical Private Limited
Amartyaa Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ragunath Priyadharshini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ragunath Priyadharshini

Ragunath Priyadharshini was first appointed on 31 May 2020 as Managing Director at Medigro Pharmaceutical Private Limited.

Ragunath Priyadharshini held 2 earlier board appointments: Medigro Pharmaceutical Private Limited (Managing Director, 31 May 2020 to 23 Feb 2021); Amartyaa Pharmaceutical Private Limited (Managing Director, 09 Dec 2020 to 16 Nov 2021).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available